HealthBeacon PLC HealthBeacon - HBCN - CFO Appointment

Healthbeacon

18/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230418:nRSR5036Wa&default-theme=true

RNS Number : 5036W  HealthBeacon PLC  18 April 2023

HealthBeacon Interim CFO appointed Chief Financial Officer

Company bolsters management team as it pursues growth

HealthBeacon plc ("HealthBeacon" or "the Company"), a leader in devices and
software to manage critical and chronic medications, today announces the
appointment of Lar Malone as Chief Financial Officer. Lar has served as
Interim CFO since joining the Company in December 2022.

A Chartered Management Accountant with significant finance and management
experience at CFO level, Lar has held a number of senior roles within the
pharmaceutical industry, including with Pfizer, Schering-Plough, Teva and
Alexion.

Jim Joyce, Co-Founder and Chief Executive of HealthBeacon, commented: "I am
very pleased that Lar has been appointed HealthBeacon's Chief Financial
Officer. Since joining the Company as Interim CFO last year, Lar has made a
significant contribution to HealthBeacon, bringing his excellent expertise to
bear within our finance function, and actively supporting the Company's growth
aspirations. Lar has extensive experience in the pharmaceutical industry and
will be a valuable asset to HealthBeacon as we continue to expand our client
base, grow technology deployments, and deliver on the significant growth
opportunity ahead."

 

 Enquiries:                                       Investor.Relations@HealthBeacon.com
 HealthBeacon:

 Jim Joyce

 Lar Malone

 Goodbody (Euronext Listing Sponsor and Broker):  +353 (1) 667 0420

 David Kearney
 Stephen Kane

 Drury (Public Relations):
 Cathal Barry                                     +353 (0) 87 227 9281
 Paul Clifford                                    +353 (0) 87 327 2161

 

About HealthBeacon

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company
that develops smart tools for managing medications for patients in the home.
The HealthBeacon Injection Care Management System tracks adherence and
persistence with medication schedules through the provision of medication
management reminders, safe and sustainable sharps disposal devices,
educational tools, and artificial intelligence (AI) driven data analytics.
Peer reviewed evidence supports a 19% improvement in therapy persistence by
patients and up to 26% improvement in adherence to therapy, which improves
clinical outcomes and significantly improves efficiency in health systems. The
Company has expanded its offering to growth management with the launch of its
integrated Smart Scale and oral adherence with the launch of HB Wave which
integrates with its existing technology. The Company operates across Europe,
North America and the United Kingdom and employs more than 70 people and has
obtained more than 30 design and utility patents. The Company's mission is to
become the world's leading digital therapeutics platform for patients managing
medications in the home.

Ends

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEUBUKROAUSAAR